Erin Maureen Duffy is Vice President, Discovery Research at Rib-X Pharmaceuticals, Inc. Rib-X Pharmaceuticals, Inc., is a privately-held biopharmaceutical company, founded in 2001, located in New Haven, Connecticut. There are 44 full-time employees. The Company has an industry-leading pipeline of novel antibiotics targeting multidrug-resistant infections in significant and growing segments of the $25 billion antibiotics market. The Rib-X portfolio has four core programs including two late-stage product candidates, Delafloxacin and Radezolid, both potentially best-in-class antibiotics being developed in market-preferred intravenous and oral formulations for maximum flexibility. Duffy is a fourth generation Irish American. Her great-great grandfather John Charles Duffy came to America from Roscommon, and worked as a railroad conductor. He also contributed money to the gun running effort in Ireland. A graduate of Yale University and Wheeling Jesuit College, Duffy and her husband William L Jorgensen reside in Deep River, CT.
Return to Life Science 50